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Prescription drug abuse is defined as the use of prescription opioids without a prescription or use 
only for the experience or feeling they cause (Substance Abuse and Mental Health Services 
Administration, 2014). Prescription drug abuse/misuse (PDA/M), in particular the abuse of 
prescription opioid (PO) medications, has reached epidemic proportions in the United States 
(Centers for Disease Control and Prevention [CDC], 2011). Substance Abuse and Mental Health 
Services Administration (2014) data indicate that there are over 4.5 million past month non-
medical users of prescription opioid medications in the U.S. alone.  
Overdose death has quadrupled since 1999, much of which is a result of prescription drug abuse 
(Chen, Hedegaard, & Warner, 2013). On average 83 opioid medications were prescribed per 100 
people in the U.S. in 2012 (Paulozzi, Mack, & Hockenberry, 2014). The state of Tennessee is 
disproportionately struggling with the prescription drug abuse epidemic and has the second 
highest oral (PO) prescribing rate per capita (Paulozzi et al.). In addition, Tennessee experienced 
a 250% increase in PO-related overdose deaths from 2001 to 2010, accounting for 7% of 
prescription drug overdose deaths nationally despite comprising only 2.3% of the nation’s 
population (CDC, 2011; Tennessee Department of Health Safety Subcabinet Working Group, 
2012).  
Neonatal Abstinence Syndrome (NAS), a condition resulting from intrauterine exposure to 
maternal prescription drugs, has also reached epidemic proportions in the Northeast region of 
Tennessee; in particular, this region accounts for a disproportionate incidence of babies born 
with NAS statewide with a rate of 41.6 per 1,000 live births versus the state rate of 11.6 per 
1,000 live births (Tennessee Department of Health, Division of Family Health and Wellness, 
2013). The geographic placement of East Tennessee State University (ETSU) and its Academic 
Health Sciences Center (AHSC) in this high PDA/M prevalence location allowed for ready 
engagement on the problem.  
ETSU is a regional public university located in this Northeast part of the state with the highest 
prevalence of PO prescribing, misuse and its resultant outcomes, addiction, overdose and NAS. 
ETSU is a Carnegie-designated Doctoral Research University with a comprehensive AHSC that 
is a member of the Association of Academic Health Centers (AAHC). 
In the past few years, a team of interprofessional scientists at ETSU has come together to address 
the problem of prescription drug abuse. Since then, they have been successful in grant writing, 
publication, public education, and are attempting to impact policy through their work. The 
purpose of this manuscript is to describe the experience of creating and maintaining this highly 
interprofessional research team, with the aim of encouraging purposeful cultivation of similar 
interprofessional teams to address significant public health needs.  
Working Group History 
In spring 2012, three ETSU researchers, four university administrators, and one community 
health care professional met to discuss the PDA/M problem and the role ETSU could play in 
addressing community and regional needs. Challenged and energized by the encounter, the 
researchers resolved to meet frequently to identify priority areas for research activities. From the 
first meeting, the group knew that the complexity of the problem would require interprofessional 
collaboration, community partnerships, teamwork, and an integrated training model that included 
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faculty and student interaction. The group sought out other individuals who shared interest in 
PDA/M, including other ETSU faculty and staff, and anti-drug coalitions in the region. Monthly 
meetings were scheduled and held on ETSU’s campus. By the end of 2012, the Working Group 
invitation list grew to more than 20 scholars, clinicians, students and community partners 
working in prevention, treatment, or other related settings. In the first year, roughly 7-10 
members would attend the meetings. By the end of 2012, the list had grown to more than 90, 
with approximately 30-35 members attending each meeting. The group developed organically. A 
formal systematic approach to engaging new members was never employed. Members learned of 
the group and joined based on their personal or professional interest in the problem, and those 
who stay engaged were frequently mapped onto new research proposals or community 
interventions. The Working Group continues to grow and sustains a high level of productivity 
due in part to the informal nature of the monthly meetings that allow scholars, students, and 
community members to brainstorm new research questions, discuss community issues, and 
implement effective interventions simultaneously. In 2015 the group began alternating monthly 
meetings between the university campus and partner agencies settings in order to maintain the 
vital connection to the community. Figure 1 below shows the diversity of the group by primary 
discipline and represents the total number of members in the PDAM Working Group by 
discipline. 
  
Figure 1. Prescription Drug Abuse Working Group Membership 
The PDA/M Working Group continues to meet monthly and is now comprised of a remarkable 
list of gifted scholars and invested community partners. The list includes nationally known 
speakers, advocates, public health practice leaders, community residents, former addicts and 
scholars.  
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The meetings usually open with a partner update that takes half or more of the meeting time. By 
beginning with this step the group provides an informal milieu that allows for connections to be 
made between projects and partners. Dozens of new activities and projects have been initiated in 
these meetings and the consistency of the meeting staff and time has provided the mechanism to 
keep track of projects and updates. 
Early on, the group identified the need for consistent research, education and practice on the 
topic and set a goal to gather the internal and external resources to ultimately create a Center for 
Prescription Drug Abuse Prevention and Treatment at ETSU. Recognizing the need for 
consistent financial support the group immediately began searching for a federally funded 
mechanism for infrastructure development.  
The concerted effort of this group resulted in the formal submission of a large-scale National 
Institute on Drug Abuse (NIDA) proposal that was funded on the first attempt in 2013. The grant 
established the ETSU Diversity-promoting Institutions Drug Abuse Research Program (ETSU-
DIDARP) called Interprofessional Communication to Reduce Prescription Drug Abuse in 
Appalachia. The program supports training and mentorship of students and faculty while 
executing three prescription drug abuse research projects. The projects are focused on 
interprofessional communication by prescribers, dispensers and patients to reduce PDA/M and a 
focused effort to increase the volume of prescription drugs that are taken to pill “drop-boxes” for 
incineration by law enforcement authorities. 
The DIDARP team represents a subset of the larger PDA/M Working Group. In fact, they are 
funded to create research infrastructure for this topic, while executing the three projects 
mentioned above. To nurture collaborative interprofessional research, the ETSU-DIDARP 
research team has conducted fortnightly research team meetings since beginning in 2013. All 
investigators, graduate students, fellows, and project staff attend each meeting. During these 
meetings project/programmatic discussions enhance scientific knowledge and application by 
linking relevant research information to the practical issues faced by the research team. By 
sharing project updates and discussing any project-specific issues in real-time with the entire 
team, the team attempts to mitigate isolation while strengthening the cohesiveness of the research 
team, addressing an Interprofessional Education Collaborative (IPEC) competency in a practical 
and hands-on manner (Interprofessional Education Collaborative Expert Panel, 2011). These 
discussions provide opportunity for all team members to develop a common knowledge base, 
generate research ideas, and collaborate across disciplines, thereby stimulating innovative 
thinking regarding both substance abuse and PDA/M in the Appalachian region. 
In June of 2014, Drs. Nick Hagemeier and Ivy Click received funding from the TN Department 
of Health to further examine Neonatal Abstinence Syndrome (NAS). For this research project, 
Drs. Click and Hagemeier target four different groups: pharmacists, primary care physicians, 
pain management clinic physicians and those prescribing buprenorphine, a drug commonly used 
to treat opioid addiction. Hagemeier and Click are examining how physicians talk to patients 
about the risks of NAS, particularly female patients who are in their childbearing years. 
Since the very first proposal, the team has worked diligently on developing new ideas and 
products. Their work has spawned policy analysis, evaluation activities, field placements for 
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graduate students, movie nights on campus and countless new activities. A few quantifiable 
measures are the number of publications, grant proposals and their interprofessional nature.  
Seven PDA/M related manuscripts have been published in peer-reviewed journals during the last 
four years. The manuscripts are analogous to the composition of the working group in that they 
are published in journals that cross multiple disciplines. 
 Prescription disposal practices:  A 2-year ecological study of drug drop box donations in 
Appalachia.  American Journal of Public Health. 2015.   
 Factors associated with provision of addiction treatment information by community 
pharmacists. Journal of Substance Abuse Treatment. 2014.  
 Theoretical exploration of Tennessee community pharmacists’ perceptions regarding 
opioid pain reliever abuse communication. Research in Social & Administrative 
Pharmacy. 2014 
 Prescription drug abuse: A comparison of prescriber and pharmacist perspectives. Drug 
Abuse: Substance Use & Misuse. 2013.  
 Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and 
outcomes in rural Appalachia. Archives of Internal Medicine. 2012.  
 Prescription drug abuse communication: A qualitative analysis of prescriber and 
pharmacist perceptions and behaviors. Research in Social and Administrative Pharmacy. 
2015.  
 Correlates of prescription opioid legitimacy estimations among community pharmacists 
in Tennessee.  Health Education and Behavior. (Under Review).  
Furthermore, the team has submitted sixteen new prescription drug-related research proposals, 
seven of which have been funded with one currently under review. The PDA/M Working Group 
and DIDARP team also host a monthly Accreditation Council for Continuing Medical Education 
(ACCME) Accredited Grand Rounds series during the academic year and present research 
findings at a number of regional and national events. In total, working group members have 
presented at more than 35 invited events, including presentations to legislative committees of the 
Tennessee House and Senate. In 2013 the team hosted the Appalachian Regional Summit on 
Prescription Drug Abuse which convened experts from across central Appalachia and included 
speakers from the White House Office of National Drug Control Policy and the Drug 
Enforcement Agency.   
Community outreach and education efforts are central to the mission of the team and 
collaborative partnerships have resulted in the development of a funded anti-drug coalition in 
Carter County, TN, a regional Naloxone Training and Access task force, and a workforce 
initiative aimed at engaging local business and industry in the adoption of comprehensive 
prevention programs and policies. In March of 2016, the culmination of these products both 
academic and collaborative resulted in formal approval for the ETSU Center for Prescription 
Drug Abuse Prevention and Treatment by the Tennessee Board of Regents. A description of the 
academic environment that contributed to the momentum of the PDA/M Working Group and 
development of the Center follows, as components may be replicable specifically when 
collaborative effort is required to address an urgent health concern.   
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The Working Group has become a fertile landscape for the development of research and 
implementation of evidenced-based strategies in the surrounding communities. As funding 
opportunities arise, personnel are selected based on research track record, readiness for the 
research effort, content expertise, and PDA/M interest. Team members must be willing to 
substantively contribute to the application process and provide scientifically valid and 
professional input. Students are mapped on to these studies as well, according to their area of 
interest and aptitude for the subject matter.  
The group maintains a website and consistently updates social media outlets to share funding 
opportunities, research progress and outcomes, training opportunities, and related legislation. 
The group’s website is www.etsu.edu/cph/pdam. 
Institutional and Regional Research Initiatives 
Interprofessional education (IPE) is at the heart of the student and faculty experience at ETSU. 
The Interprofessional Education & Research Committee (IPERC) operates at the Academic 
Health Sciences Center (AHSC) level and is charged with assuring a path for interprofessional 
competency attainment by all AHSC graduate and professional students, a goal supported by the 
AHSC Deans and the Vice President for Health Affairs. Given cultural and regional barriers to 
health care, IPE is a necessity to address regional health disparities. 
The ETSU-DIDARP team has built much of its work around the Appalachian Research Network 
or AppNET. AppNET is a Health Services and Resources Administration (HRSA)-funded, rural 
Appalachian Practice-Based Research Network (PBRN), and the framework from which we 
conduct most ETSU-DIDARP projects. AppNET is housed within the ETSU College of 
Medicine and currently has 20 clinic groups with approximately more than 100 physicians and 
32 mid-level providers actively participating in AppNET activities. Presently, AppNET has 
several research efforts that involve working with member clinics on their medication 
reconciliation process to reduce adverse medication events; developing an automated clinic data 
mapping system that will provide clinics with quality improvement data; and determining the 
factors that are associated with the prescribing of control medications. One goal of the ETSU-
DIDARP project is to expand AppNET infrastructure to include community pharmacies and 
local health departments in the region. This development is necessary to facilitate collaborative 
project activities that would not be possible without this infrastructure. Furthermore, this 
expansion maximizes the potential of past and future investments in the regional PBRN 
infrastructure. 
Interprofessional Stakeholders 
Regional health care providers and community stakeholders have been at the forefront of a 
grassroots effort to “do something” about PDA/M in Northeast Tennessee. ETSU has a rich 
tradition of community-based engagement with health issues, perhaps more so when compared 
to other institutions given the relatively small cities and rural culture of the area. As an example 
of community support, the team has partnered with primary care clinics, pediatrics clinics, pain 
management clinics, pharmacies, regional substance abuse coalitions and health departments. 
The Working Group includes several clinical care providers of both abstinence-oriented and 
medication-assisted substance abuse treatment. 
5
Pack et al.: The ETSU Prescription Drug Abuse/Misuse Working Group
Published by Digital Commons @ East Tennessee State University, 2016
Importantly, one key stakeholder is the Tennessee Commissioner for Health, John Dreyzehner, 
MD, MPH, a national expert on prescriber efforts to mitigate harm from PDA/M and NAS. He 
was instrumental in creating legislation to mandate prescriber and pharmacist use of the 
Tennessee Controlled Substance Monitoring Database (CSMD). The law, signed by the 
Governor in April 2012, took effect in January 2013. Commissioner Dreyzehner was also 
instrumental in helping Governor Bill Haslam to develop a 25-point State of Tennessee strategy 
to reduce PDA/M and is responsible for implementing more than half of the items on the plan.  
Dr. Dreyzehner is on the External Advisory Board of the DIDARP Program and consults with 
the leadership of the PDA/M Working Group team as needed. 
ETSU students are similarly invested and interested in PDA/M research. Many have not only 
been exposed to PDA/M problems in classroom settings, they or their families have lived it.  
Students have lost loved ones to prescription drug overdoses, become addicted to prescription 
drugs themselves, or have experienced the community-level impact of PDA/M. Graduate and 
professional students are conducting PDA/M research with ETSU-DIDARP personnel and many 
are taking their knowledge to the regional communities. As an example, Gatton College of 
Pharmacy and Quillen College of Medicine students established a Generation Rx team that 
makes PDA/M presentations to local high school and junior high students. To date, the 
Generation Rx group, under the direction of Dr. Sarah Melton, has reached over 2,000 students. 
This group has also developed an AHSC-supported provider toolkit specific to PDA/M. Within 
the College of Pharmacy, over 40 future pharmacists (nearly 20% of eligible students) are 
choosing to take research electives every semester; several of which are related to substance 
abuse. One of the team members has shared her mother’s story of painkiller addiction on 
National Public Radio and frequently tours with her mother, a recovering pain medication addict, 
to educate the public. Finally, it should be noted that several students in public health are 
working with the authors of this work on PDA/M topics for their dissertation or capstone 
projects. 
In order to foster continued professional development, faculty, students and staff are invited to 
participate in multidisciplinary PDA/M Journal Club and ACCME Accredited Grand Rounds 
activities on a monthly basis. These events expose members of the team to multidisciplinary 
research projects that have been conducted and published by research peers across the country, 
which allows for cross-pollination between research disciplines and encourages innovative 
discussions regarding substance abuse/misuse in the Appalachian region. These sessions are 
expected to enrich both current and future research within the AHSC. 
The PDA/M Working Group and the ETSU-DIDARP team have established a milieu for 
successful conduct of research on campus via its meeting, grand rounds and journal club efforts. 
The team has also engaged in several measures to increase interprofessional research capacity on 
campus. Below, two examples of that capacity are offered: the faculty development series and 
the detailed student assessment. 
Faculty Development for Interprofessional PDA/M Research 
Academic and continuing educational coursework is fundamental for the faculty who are 
formally participating in the program as investigators or staff. Options for training depend on the 
course of study for the students and the specific learning objectives for the faculty. A set of 
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courses and training activities was established for the faculty and students enrolled in the 
program. Current and to-be-developed courses used by the team for training of the participants 
are found in Table 1. The Working Group will participate in the development of additional 
courses based on research competency needs. 
Table 1.  Courses and Training available for Faculty and Students 
Course: Description: Resource: 
Risk Behavior 
Epidemiology 
An introduction to the epidemiology of risk behaviors and 
the application of risk behavior research including 
concepts/theory of health/risk behavior, major risk behaviors, 
determinants of risk behaviors, risk behavior and the health 
care delivery system, and the future of risk behavior 
research. 
EPID course 
number to be 
determined 
 
Grant Writing Instruction in grant writing, including the development of a 
long-term research agenda, the identification of funding 
sources for research, advance planning for grant proposals, 
and an introduction to writing grant proposals. Emphasizes 
refinement of writing skills, development of an 
organizational vision, budget development, and budget 
justification, goal-setting and political realities. 
Faculty:  
GRAD 7820 
& GRAD 
7830  
Students:  
ELPA 6955 
Evidence-Based 
Public Health   
Provides skills for using best practices and other evidence-
based methods as components of a systematic approach to 
finding effective interventions to community health 
challenges in diverse populations. 
COBH 6250 
Communication 
Theory   
Examines the study of traditional, modern, and emerging 
communication theories as analytical tools to understand 
how communication operates in a variety of settings.  
SPCH 5330 
 
Interdisciplinary 
Research   
An introduction to the nature and value of interdisciplinary 
study. Literature, scientific theory, critical theory, and/or 
social science, historical, and philosophical constructs may 
be brought to bear on the study of interdisciplinarity.  
MALS 5100 
 
Alcohol and 
Drug Abuse   
A basic understanding of alcohol and drug abuse. Various 
classifications of drugs, specific abuse symptomatology, 
specific causes of drug abuse, characteristics of high-risk 
groups, various treatment models, preventative efforts, and 
regulations controlling the use of drugs in society are 
examined.  
 
SOWK 5367 
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Substance 
Abuse and 
Addiction in 
Appalachia 
An integrated study of the history, physical, sociocultural, 
and psychological effects of substance abuse and the 
underlying disease of addiction. Place and social 
determinants of health are explored as causes of addition in 
Appalachia.  Expert panelists are used. 
PMPR 7118 
Non-Medicinal 
Drug Use  
 
Topics centered around the use of drugs for non-medicinal 
purposes, discussion on the continuum of legitimate versus 
non-legitimate drug use, or medical versus non-medical use.  
The major focus of the subject material pertains to issues of 
drug abuse, particularly in Appalachia and other rural 
environments.   
PMSC 7203 
 
 
Student Development for Interprofessional PDA/M Research  
Students are integral to the success of the research program as the team strives to develop a cadre 
of experts to carry on PDA/M research. The team is intentional in creating an environment that 
engages students from diverse backgrounds in regional PDA/M prevention efforts, creates 
interest in PDA/M research careers, and provides mentoring that is fruitful and constructive. 
Undergraduate student development consists primarily of research shadowing and volunteer 
opportunities with project researchers and staff. Undergraduate students are paired with graduate 
students conducting PDA/M research activities, forming a mentor/protégé relationship. Dr. 
Hagemeier participated in the development and implementation of a graduate student/pre-
pharmacy student mentor/mentee program during his graduate education (Kiersma et al., 2012), 
and a similar process is employed at ETSU to expose undergraduate students to research through 
informal mentoring activities. At the discretion of ETSU-DIDARP faculty members, 
undergraduate students may be given additional research responsibilities (e.g., data entry and 
analysis and research proposal development).  
Graduate students and fellows are essential members of the research team and actively 
participate in team meetings and monthly PDA/M Working Group meetings. Their development 
plan is based on core research competencies promulgated by the National Postdoctoral 
Association (NPA). NPA competencies include:  
1) discipline-specific conceptual knowledge;  
2) research skill development;  
3) communication skill development;  
4) professionalism;  
5) leadership and management skill development; and  
6) responsible conduct of research (National Postdoctoral Association Core 
Competencies Committee, 2009).   
 
Development activities can be divided into three core areas: graduate-level coursework, 
mentoring, and experiences gained through active participation in team research. Students serve 
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as research assistants for the program, spending on average 80 hours monthly gaining hands-on 
PDA/M research experience. Graduate students routinely present journal club articles to the team 
and solicit input from team members regarding proposed graduate student research projects. 
Mentoring takes place at the advisor level as well as at the project team level. The strong 
collaborative relationships within the project team and PDA/M Working Group promote 
interdisciplinary mentoring relationships. For example, College of Public Health graduate 
students have developed mentor/protégée relationships with College of Medicine and College of 
Pharmacy faculty members. Doctor of Pharmacy (PharmD) students develop PDA/M research 
skills through participation in research electives with program faculty members. Dual-degree 
(MD/MPH, PharmD/MPH) students participate in DIDARP activities through completion of 
research electives or through extracurricular participation in research activities as deemed 
appropriate by team researchers. Professional student experiences include mentor-guided 
research training.  
The ETSU-DIDARP Program provides funding for Community Pharmacy Research Fellows. 
The fellows’ development is similar to graduate training in the College of Public Health and is 
designed to provide a strong foundation in research skills development. In addition to graduate-
level coursework and participation in program research activities, the fellows focus on applying 
PDA/M research concepts in pharmacy practice settings. Fellows actively participate in research 
team and PDA/M Working Group meetings, enroll in the MPH program and complete activities 
and coursework as described below. Presentation of team project research at national meetings is 
an expectation of fellows.  
The rubric for the formative DIDARP was developed from the NPA core competencies, and is 
utilized to assess graduate student research skill development annually. Students self-assess their 
progress and external assessments are conducted by primary research advisors. The ETSU-
DIDARP program represents a model for mentoring that is frequent, nurturing, consistent and 
focused on academic products. 
Congruent with the theme of mentoring, the team supports internal peer review for manuscripts 
and grant proposals. Internal peer review serves to increase competitiveness of proposals and 
papers that are reviewed. Planning for the process in terms of time forces the principal 
investigator to prepare early and give them time to make corrections when pointed out by peer 
reviewers. Sophisticated research universities regularly peer review their products before 
submission and this infrastructure is crucial to develop at our university. 
Infrastructure Development for Interprofessional PDA/M Research 
As a historically strong health sciences teaching university with deep roots in clinical care, 
community partnerships and rural health, the infrastructure for research activities has been a 
second priority, until recently. In order to compete at the national level for research funding, 
several issues can be addressed alongside this interprofessional PDA/M prevention effort.  
It is important that the university develops research infrastructure to support long-term strategic 
initiatives to improve health. The formation of interprofessional research centers is an essential 
step in the framework of research development. Prior to the establishment of the Center for 
Prescription Drug Abuse Prevention and Treatment the university had only one research center 
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for health. ETSU recently celebrated its 100th anniversary and shortly thereafter began the 
visioning process for 2037 through establishment of the Committee for 125 (www.etsu.edu/125). 
One of the subcommittees developed a plan for research growth as one of the greatest 
opportunities and necessities for the university in the coming quarter century.  
In 2013, the ETSU president formed an ad-hoc committee to develop a strategic plan to grow 
research at the university. The recommendations are consistent with the visioning for 125. 
Interprofessional research is a cornerstone of the plan.  
Discussion 
The overarching goal of the newly established Center for Prescription Drug Abuse Prevention 
and Treatment is to strengthen research infrastructure and foster research career development on 
multiple levels. Accomplishment of these goals will establish multiple lines of PDA/M-related 
research. The results of this work could transform the career paths of many of our junior faculty 
and undergraduate, professional, and graduate students. Moreover, with high quality, nationally 
competitive research being conducted at ETSU that is focused on PDA/M, the team has the 
potential to bend the curve on the problem, beginning in the region and impacting the work in the 
state and nation.   
We feel strongly that ETSU should be one of the major hubs for prescription drug abuse research 
in Appalachia. We aim for our work to attract additional researchers to ETSU and therefore 
positively impact the number and quality of researchers focused on the topic. Our local substance 
abuse prevention coalitions are strong partners of the team and we anticipate increased 
collaboration with state and regional substance abuse coalitions, Tennessee’s Controlled 
Substance Monitoring Database Advisory Council, Tennessee Department of Health, and other 
regional stakeholders.  
Conclusion 
The AHSC at East Tennessee State University has a highly trained, interprofessional faculty that 
serves the region and is committed to combating prescription drug abuse and misuse in 
Appalachia. PDA/M is a national problem and one for which control measures are urgently 
needed. The collective impact that has been achieved by bringing together scholars and 
community leaders in a collaborative and supportive institutional environment can be replicated. 
Center staff are currently engaged in establishing a formal partnership with Mountain States 
Health Alliance, a regional health care system, to create a comprehensive, not for profit, opioid 
treatment program that will ultimately help fund Center prevention initiatives across the region. 
This clinical component of the newly established Center will also allow for ongoing research to 
support continued infrastructure development and attract extramural funding. Looking forward, 
the team plans to convene interested universities across central Appalachia to begin a 
conversation about how we might work together on a systematic and concerted plan to address 
this problem at each point along the continuum of disease.  
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